MarginsXMarginsX
Home › Markets › Consumer Staples › CVS

CVS Health Corporation (CVS)

CVS trades on NYSE in Consumer Staples, Retail-Drug Stores and Proprietary Stores. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$88.59
-0.85% on the day
Market cap
$113.3B
Large cap
Revenue · 2025
$402.1B
+7.8% on 2024
Net income · 2025
$1.8B
0.4% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/64803/000006480326000010/0000064803-26-000010-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerCVS on NYSE
SectorConsumer Staples
IndustryRetail-Drug Stores and Proprietary Stores
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0000064803
SEC industry codeRetail-Drug Stores and Proprietary Stores
Incorporated inDE

Financials · 2025

LineValue
Revenue$402.1B
Net income$1.8B
Operating income$4.7B
Net margin0.4%
Operating margin1.2%
Revenue growth+7.8%
Cash$8.5B
Total assets$253.5B
P/E (computed)64.1×
P/S (computed)0.3×

Warning signs

Cash runway
Cash-flow positive
$11.7B cash at September 30, 2026
Share count, 1 year
+0.8%
2025-10-22 to 2026-10-28 · -0.6% over 3 years
Going-concern doubt
No
10-Q filed November 4, 2026
Insider net buying, 12 months
-$323.7M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-04
Cash and burn$11.7B cash; operating cash flow $4.7B a quarter.Report 2026-09-30
Shares outstanding1,279,474,188 (2026-10-28); 1,269,432,485 a year earlier; 1,286,896,582 three years earlier.Cover page 2026-10-28
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-05-22
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorErnst & Young LLP, Boston, Massachusetts, United StatesPCAOB Form AP 2026-03-05
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $323.7M on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$108.4B$2.2B$4.7B$11.7B$60.7B$420.6B10-Q 2026-11-04
Q2 2026
2026-06-30
$106.1B$3.0B$6.3B$11.3B$61.4B$415.1B10-Q 2026-08-05
Q1 2026
2026-03-31
$100.4B$2.9B$4.2B$9.5B$63.1B$407.9B10-Q 2026-05-06
Q4 2025
2025-12-31
$105.7B$2.9B$3.4B$8.5B$64.6B$402.1B10-K 2026-02-10
Q3 2025
2025-09-30
$102.9B-$4.0B$796.0M$9.1B$65.8B$394.1B10-Q 2026-11-04
Q2 2025
2025-06-30
$98.9B$1.0B$1.9B$11.8B$66.5B$386.6B10-Q 2026-08-05
Q1 2025
2025-03-31
$94.6B$1.8B$4.6B$10.1B$64.7B$379.0B10-Q 2026-05-06
Q4 2024
2024-12-31
$97.7B$1.6B$1.9B$8.6B$66.3B$372.8B10-K 2026-02-10

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering documentS-3ASR2026-05-22
Latest annual report10-K2026-02-10
Latest quarterly / interim10-Q2026-11-04
Latest current report8-K2026-11-04
Latest proxy
DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS
DEFA14A2026-04-03

Source: SEC EDGAR submissions feed, 1,001 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+6.6%
1 month+2.1%
3 months-5.9%
Year to date+12.6%
1 year+12.8%
From 52-week high-19.2%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Retail-Drug Stores and Proprietary Stores

TickerCompanyPriceDayMarket cap
GRDNGuardian Pharmacy Services Inc.$49.43-0.18%$3.1B
YI111 Inc.$2.84-0.35%$25.0M
PETSPetMed Express Inc.$0.8977-4.52%$20.0M
RDGTRidgetech Inc.$1.01-4.72%$3.7M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier